Tcr2 Therapeutics Overview
Tcr2 Therapeutics Discounted Cash Flow
DCF Analysis for TCRR.
Get informed when a big investor buys or sells
+ FollowFair Value
$9.43
Current Fair Value
$9.43
↑ 537.3% Upside
Undervalued by 537.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison